Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.
Fasching PA, Heusinger K, Haeberle L, Niklos M, Hein A, Bayer CM, Rauh C, Schulz-Wendtland R, Bani MR, Schrauder M, Kahmann L, Lux MP, Strehl JD, Hartmann A, Dimmler A, Beckmann MW, Wachter DL. Fasching PA, et al. Among authors: schrauder m. BMC Cancer. 2011 Nov 14;11:486. doi: 10.1186/1471-2407-11-486. BMC Cancer. 2011. PMID: 22081974 Free PMC article.
Diabetes and prognosis in a breast cancer cohort.
Schrauder MG, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, Wachter DL, Schulz-Wendtland R, Adamietz B, Beckmann MW, Loehberg CR. Schrauder MG, et al. J Cancer Res Clin Oncol. 2011 Jun;137(6):975-83. doi: 10.1007/s00432-010-0960-2. Epub 2010 Dec 5. J Cancer Res Clin Oncol. 2011. PMID: 21132511
Hormone replacement therapy and prognosis in ovarian cancer patients.
Hein A, Thiel FC, Bayer CM, Fasching PA, Häberle L, Lux MP, Renner SP, Jud SM, Schrauder MG, Müller A, Wachter D, Strehl J, Hartmann A, Beckmann MW, Rauh C. Hein A, et al. Among authors: schrauder mg. Eur J Cancer Prev. 2013 Jan;22(1):52-8. doi: 10.1097/CEJ.0b013e328355ec22. Eur J Cancer Prev. 2013. PMID: 22694828
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
Wunderle M, Gass P, Häberle L, Flesch VM, Rauh C, Bani MR, Hack CC, Schrauder MG, Jud SM, Emons J, Erber R, Ekici AB, Hoyer J, Vasileiou G, Kraus C, Reis A, Hartmann A, Lux MP, Beckmann MW, Fasching PA, Hein A. Wunderle M, et al. Among authors: schrauder mg. Breast Cancer Res Treat. 2018 Aug;171(1):85-94. doi: 10.1007/s10549-018-4797-8. Epub 2018 May 3. Breast Cancer Res Treat. 2018. PMID: 29725888
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
Fasching PA, Loehberg CR, Strissel PL, Lux MP, Bani MR, Schrauder M, Geiler S, Ringleff K, Oeser S, Weihbrecht S, Schulz-Wendtland R, Hartmann A, Beckmann MW, Strick R. Fasching PA, et al. Among authors: schrauder m. Breast Cancer Res Treat. 2008 Nov;112(1):89-98. doi: 10.1007/s10549-007-9822-2. Epub 2007 Nov 30. Breast Cancer Res Treat. 2008. PMID: 18049890
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians.
Thiel FC, Schrauder MG, Fasching PA, Löhberg CR, Bani MR, Häberle L, Tänzer T, Radosavac D, Scharl A, Bauerfeind I, Gesslein J, Schulte H, Overbeck-Schulte B, Beckmann MW, Lux MP. Thiel FC, et al. Breast Cancer Res Treat. 2012 Oct;135(3):811-20. doi: 10.1007/s10549-012-2218-y. Epub 2012 Aug 30. Breast Cancer Res Treat. 2012. PMID: 22933029 Clinical Trial.
65 results